Breaking News Instant updates and real-time market news.

MLCO

Melco Resorts & Entertainment

$22.08

0.56 (2.60%)

08:47
08/20/18
08/20
08:47
08/20/18
08:47

Melco Resorts & Entertainment subsidiary provides update on IPO

Studio City International provided an update to its announcement made on August 14, 2017 regarding the confidential submission of a draft registration statement for the proposed initial public offering, or IPO, of American Depositary Shares, or ADS, representing ordinary shares of Studio City. Studio City has been continuing its preparations for the proposed IPO, which is expected to commence as market conditions permit and remains subject to the SEC declaring the registration statement effective. The ADSs may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

MLCO Melco Resorts & Entertainment
$22.08

0.56 (2.60%)

02/26/18
LYON
02/26/18
INITIATION
LYON
Outperform
Melco Resorts & Entertainment initiated with an Outperform at CLSA
03/08/18
STFL
03/08/18
NO CHANGE
STFL
Stifel returns from Macau trip with 'much more positive' view for 2018
Stifel analyst Steven Wieczynski said that after meeting with property managements and industry contacts in Macau recently he came back with a "much more positive/constructive view for 2018" than he was previously forecasting. It was clear that operators were "thrilled" with how the Chinese New Year holiday played out and demand post-CNY had continued to be strong, especially on the VIP side, Wieczynski tells investors. He maintains his Buy rating on Las Vegas Sands (LVS) and Hold ratings on MGM Resorts (MGM) and Wynn Resorts (WYNN). Melco Resorts (MLCO) is another publicly traded company in the Macau gaming space.
07/10/18
WOLF
07/10/18
UPGRADE
WOLF
Outperform
Melco Resorts upgraded to Outperform from Peer Perform at Wolfe Research
07/23/18
ROTH
07/23/18
NO CHANGE
Target $41
ROTH
Buy
Melco shares are 'near a bottom,' says Roth Capital
Despite lowering his Q2 EBITDA estimate, Roth Capital analyst David Bain believes shares of Melco Resorts & Entertainment are "near a bottom." The analyst lowered his Q2 property EBITDA estimate to $348.4M from $355.3M, below the consensus at $377.8M, to reflect a final surge of construction disruption at Melco's flagship, City of Dreams, ahead of the June 15 opening of Morpheus, and slightly lower than anticipated May and June Macau gross gaming revenue. The stock's multiple is now near historical lows, which is "not sustainable," Bain tells investors in a research note. He keeps a Buy rating on Melco Resorts & Entertainment with a $41 price target.

TODAY'S FREE FLY STORIES

PFE

Pfizer

$42.26

-0.26 (-0.61%)

05:31
01/23/19
01/23
05:31
01/23/19
05:31
Downgrade
Pfizer rating change  »

Pfizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 29

    Jan

  • 18

    May

XOM

Exxon Mobil

$71.89

-1.09 (-1.49%)

05:30
01/23/19
01/23
05:30
01/23/19
05:30
Hot Stocks
Exxon Mobil, REG enter joint research agreement with Clariant »

ExxonMobil and Renewable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 10

    Feb

MYL

Mylan

$28.90

-0.68 (-2.30%)

05:30
01/23/19
01/23
05:30
01/23/19
05:30
Downgrade
Mylan rating change  »

Mylan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTS

Zoetis

$84.07

-0.55 (-0.65%)

05:29
01/23/19
01/23
05:29
01/23/19
05:29
Initiation
Zoetis initiated  »

Zoetis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

MDGL

Madrigal Pharmaceuticals

$114.07

-5.76 (-4.81%)

05:28
01/23/19
01/23
05:28
01/23/19
05:28
Initiation
Madrigal Pharmaceuticals initiated  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$80.66

-2.42 (-2.91%)

05:27
01/23/19
01/23
05:27
01/23/19
05:27
Initiation
Alnylam initiated  »

Alnylam initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$31.00

-0.53 (-1.68%)

05:26
01/23/19
01/23
05:26
01/23/19
05:26
Initiation
Elanco initiated  »

Elanco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$18.75

-0.06 (-0.32%)

05:24
01/23/19
01/23
05:24
01/23/19
05:24
Upgrade
Teva rating change  »

Teva upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

LBRT

Liberty Oilfield Services

$14.90

-0.33 (-2.17%)

05:23
01/23/19
01/23
05:23
01/23/19
05:23
Hot Stocks
Liberty Oilfield Services announces additional $100M share repurchase plan »

Liberty Oilfield Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

ICPT

Intercept

$110.76

-2.56 (-2.26%)

05:22
01/23/19
01/23
05:22
01/23/19
05:22
Initiation
Intercept initiated  »

Intercept initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

LLY

Eli Lilly

$117.06

0.51 (0.44%)

05:19
01/23/19
01/23
05:19
01/23/19
05:19
Initiation
Eli Lilly initiated  »

Eli Lilly initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 13

    Feb

  • 18

    May

NKTR

Nektar

$44.74

-1.48 (-3.20%)

, BMY

Bristol-Myers

$49.71

-0.44 (-0.88%)

05:17
01/23/19
01/23
05:17
01/23/19
05:17
Recommendations
Nektar, Bristol-Myers, Pfizer analyst commentary  »

Mizuho sees…

NKTR

Nektar

$44.74

-1.48 (-3.20%)

BMY

Bristol-Myers

$49.71

-0.44 (-0.88%)

PFE

Pfizer

$42.26

-0.26 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 28

    Jan

  • 29

    Jan

  • 28

    Feb

  • 18

    May

  • 20

    May

APHA

Aphria

$7.07

0.41 (6.16%)

05:12
01/23/19
01/23
05:12
01/23/19
05:12
Hot Stocks
Aphria urges holder to take no action regarding takeover bid by Green Growth »

Aphria confirmed that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COHU

Cohu

$17.43

-0.295 (-1.66%)

05:11
01/23/19
01/23
05:11
01/23/19
05:11
Downgrade
Cohu rating change  »

Cohu downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANSS

Ansys

$160.84

-0.79 (-0.49%)

05:09
01/23/19
01/23
05:09
01/23/19
05:09
Hot Stocks
Ansys to acquire Granta Design, terms not disclosed »

ANSYS announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.50

-3.02 (-3.20%)

05:09
01/23/19
01/23
05:09
01/23/19
05:09
Downgrade
Lowe's rating change  »

Lowe's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 27

    Feb

  • 03

    Mar

ATRA

Atara Biotherapeutics

$35.47

-1.72 (-4.62%)

05:05
01/23/19
01/23
05:05
01/23/19
05:05
Initiation
Atara Biotherapeutics initiated  »

Mizuho starts Atara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGCO

Agco

$62.76

-1.93 (-2.98%)

04:59
01/23/19
01/23
04:59
01/23/19
04:59
Downgrade
Agco rating change  »

Agco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 06

    Feb

  • 07

    Feb

LOGI

Logitech

$33.69

0.24 (0.72%)

04:57
01/23/19
01/23
04:57
01/23/19
04:57
Upgrade
Logitech rating change  »

Logitech upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNP

TEN, Ltd.

$3.30

-0.09 (-2.65%)

04:56
01/23/19
01/23
04:56
01/23/19
04:56
Downgrade
TEN, Ltd. rating change  »

TEN, Ltd. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Stephens building materials analyst to hold group dinner »

Building Materials…

HSKA

Heska

$97.20

0.46 (0.48%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Heska management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
UBS software analyst to hold an analyst/industry conference call »

Software Analyst Jennifer…

ENLK

EnLink Midstream Partners

$13.30

-0.28 (-2.06%)

, ENLC

EnLink Midstream

$11.51

-0.24 (-2.04%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
EnLink Midstream Companies to hold a special shareholder meeting »

Special Shareholder…

ENLK

EnLink Midstream Partners

$13.30

-0.28 (-2.06%)

ENLC

EnLink Midstream

$11.51

-0.24 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

04:55
01/23/19
01/23
04:55
01/23/19
04:55
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

January Richmond Fed…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.